ZAI LAB LIMITED RESTRICTED SHARE AWARD AGREEMENTRestricted Share Award Agreement • August 6th, 2024 • Zai Lab LTD • Pharmaceutical preparations
Contract Type FiledAugust 6th, 2024 Company IndustryThis award evidences the grant of Restricted Shares represented by [ADSs / Ordinary Shares] (the “Award”) by Zai Lab Limited (the “Company”), on [________] to [___________] (the “Grantee”) pursuant to and subject to the terms of the Zai Lab Limited 2024 Equity Incentive Plan (as amended from time to time, the “Plan”).
ADDENDUM TO COLLABORATION AND LICENSE AGREEMENTLicense Agreement • August 6th, 2024 • Zai Lab LTD • Pharmaceutical preparations
Contract Type FiledAugust 6th, 2024 Company IndustryThis Addendum to Collaboration and License Agreement (this “Addendum”) is entered into as of April 1, 2024 (the “Addendum Effective Date”) by and between argenx BV, a private limited company organized under the laws of Belgium with its principal place of business at Industriepark Zwijnaarde 7, 9052 Zwijnaarde (Ghent), Belgium (“Licensor”), Zai Auto Immune (Hong Kong) Limited, a Hong Kong company, with an address at Room 2301, 23F, Island Place Tower, 510 King’s Road, North Point, Hong Kong (“Licensee”) and, solely with respect to Section 15.16 (Parent Guarantee) of the License Agreement, Zai Lab Limited, a China company, with an address at 4F, Bldg 1, Jinchuang Plaza 4560 Jinke Rd, Shanghai, China, 201210 (“Parent”). Licensor and Licensee are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
ZAI LAB LIMITED RESTRICTED SHARE UNIT AWARD AGREEMENTRestricted Share Unit Award Agreement • August 6th, 2024 • Zai Lab LTD • Pharmaceutical preparations
Contract Type FiledAugust 6th, 2024 Company IndustryThis agreement (this “Agreement”) evidences an award (the “Award”) of Restricted Share Units granted by Zai Lab Limited (the “Company”) to the individual named above (the “Grantee”), pursuant to and subject to the terms of the Zai Lab Limited 2024 Equity Incentive Plan (as amended from time to time, the “Plan”).
ZAI LAB LIMITED 2024 EQUITY INCENTIVE PLAN NON_STATUTORY SHARE OPTION AWARD AGREEMENTNon_statutory Share Option Award Agreement • August 6th, 2024 • Zai Lab LTD • Pharmaceutical preparations
Contract Type FiledAugust 6th, 2024 Company IndustryThis agreement (this “Agreement”) evidences a Share Option granted by Zai Lab Limited (the “Company”) to the individual named above (the “Optionee”), pursuant to and subject to the terms of the Zai Lab Limited 2024 Equity Incentive Plan (as amended from time to time, the “Plan”).